))
Episode 25: Weighing the Risks and Benefits of GLP-1 Medications
Manage episode 451155256 series 3593068
Contenido proporcionado por Loni and Christine. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Loni and Christine o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
In this episode we dive into the world of GLP-1 receptor agonists - the class of medications (e.g., Ozempic and Wegovy) making headlines for their role in weight management and diabetes care. We explore the science behind GLP-1 medications, their impact on metabolic health, and their growing popularity beyond diabetes treatment. However, it's not all smooth sailing; side effects, accessibility, and long-term outcomes are part of the conversation, too. Whether you're a healthcare professional, a curious patient, or interested in the latest medical advancements, this balanced discussion will help you better understand this groundbreaking class of medications.
Email us! [email protected]
Hosted on: https://findingthebalancewithloniandchristine.buzzsprout.com
32 episodios
Compartir
